NCT/Study#

ATX-NS-001

An Open-Label, Multi-Centre Phase I/IIa Study Evaluating the Safety and Clinical Activity of Neoantigen Reactive T Cells in Patients With Advanced Non-Small Cell Lung Cancer

An Open-Label, Multi-Centre Phase I/IIa Study Evaluating the Safety and Clinical Activity of Neoantigen Reactive T Cells in Patients With Advanced Non-Small Cell Lung Cancer

DISEASE GROUP:
Phase 1
current phase:
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: